Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI

Sponsor
University Hospital Muenster (Other)
Overall Status
Completed
CT.gov ID
NCT04665414
Collaborator
(none)
103
1
40.1
2.6

Study Details

Study Description

Brief Summary

comparison of transvaginal ultrasound, transvaginal ultrasound elastography and MRI for the diagnosis of adenomyosis in patients receiving hysterectomy afterwards

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: MRI
  • Diagnostic Test: transvaginal ultrasound
  • Diagnostic Test: transvaginal ultrasound elastography

Study Design

Study Type:
Observational
Actual Enrollment :
103 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Value of Transvaginal Ultrasound, Transvaginal Sonographic Elastography and MRI for the Diagnosis of Adenomyosis
Actual Study Start Date :
Sep 29, 2017
Actual Primary Completion Date :
Jan 1, 2021
Actual Study Completion Date :
Jan 31, 2021

Outcome Measures

Primary Outcome Measures

  1. sensitivity MRI [through study completion, an average of 1 year]

    sensitivity MRI

  2. specificity MRI [through study completion, an average of 1 year]

    specificity MRI

  3. sensitivity transvaginal ultrasound [through study completion, an average of 1 year]

    sensitivity transvaginal ultrasound

  4. specificity transvaginal ultrasound [through study completion, an average of 1 year]

    specificity transvaginal ultrasound

  5. sensitivity transvaginal ultrasound elastography [through study completion, an average of 1 year]

    sensitivity transvaginal ultrasound elastography

  6. specificity transvaginal ultrasound elastography [through study completion, an average of 1 year]

    specificity transvaginal ultrasound elastography

  7. sensitivity intraoperative ENZIAN FA [through study completion, an average of 1 year]

    sensitivity intraoperative ENZIAN FA

  8. specificity intraoperative ENZIAN FA [through study completion, an average of 1 year]

    specificity intraoperative ENZIAN FA

Secondary Outcome Measures

  1. sensitivity and specificity of single sonographic or MRI criteria or combinations thereof [through study completion, an average of 1 year]

    sensitivity and specificity of single sonographic or MRI criteria or combinations thereof

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • dysmenorrhea

  • dyspareunia

  • non cyclic lower abdominal pain

  • hypermenorrhea

  • menometrorrhaghia

  • pain while compressing the Uterus during gyn exam

  • Patient wants to participate

  • Patient will receive hysterectomy

Exclusion Criteria:
  • Patient declines to participate

  • contraindications against MRI

  • contraindications against ultrasound

  • minor

  • cannot give informed consent

  • no hysterectomy planned

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Muenster Münster NRW Germany 48149

Sponsors and Collaborators

  • University Hospital Muenster

Investigators

  • Principal Investigator: se D Schaefer, MD PhD, University Hospital Muenster, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. med. Sebastian Daniel Schäfer, Head of Gynecology, University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT04665414
Other Study ID Numbers:
  • Schäfer_Adenomyosis
First Posted:
Dec 11, 2020
Last Update Posted:
Apr 28, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. med. Sebastian Daniel Schäfer, Head of Gynecology, University Hospital Muenster
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2021